GleamWall
中文EN

RCEL AVITA Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1762303 · Fiscal year ends 12/31

Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.6%
TTM net income YoY15.3%
TTM EPS YoY18.8%
Revenue 3-yr CAGR31.4%
Net income 3-yr CAGR—

Margins

Gross margin83.7%
Operating margin-58.1%
Net margin-67.1%
FCF margin-51.3%
EBITDA margin-55.7%

Returns

ROE-1,746.3%
ROA-67.1%
ROIC (approx.)-117.7%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets110.5%
Debt / equity—
Current ratio0.67x
Interest coverage-8.33x

Cash quality & payout

Operating cash flow / net income0.70x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue4.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$71.61M$64.25M
Cost of revenue$12.79M$9.09M
Gross profit$58.82M$55.16M
R&D expense$20.84M$20.36M
SG&A expense$27.37M$33.20M
Operating income-$42.53M-$56.59M
Interest expense$5.00M$5.36M
Pretax income-$48.58M-$61.79M
Income tax$11,000$54,000
Net income-$48.59M-$61.84M
EBITDA-$40.19M-$55.47M
EPS (basic)-1.74-2.39
EPS (diluted)-1.74-2.39
Weighted avg. shares (diluted)27.86M25.88M
Banking
Provision for credit losses-$10,000$23,000
Balance sheet
Cash & equivalents$10.24M$14.05M
Short-term investments$7.94M$21.84M
Receivables$9.09M$11.80M
Inventory$6.93M$7.27M
Current assets$35.49M$57.00M
PP&E, net$8.63M$10.02M
Intangibles$5.64M$5.57M
Total assets$56.39M$79.71M
Current liabilities$62.68M$20.16M
Short-term debt$42.98M$0
Long-term debt$0$42.24M
Total debt$42.98M$42.24M
Total liabilities$73.04M$74.97M
Shareholders' equity-$16.65M$4.50M
Net debt$32.74M$28.20M
Shares outstanding30.57M26.35M
Cash flow statement
Operating cash flow-$31.20M-$48.94M
Capital expenditure$1.00M$9.17M
Free cash flow-$32.20M-$58.11M
Investing cash flow$12.45M$37.36M
Financing cash flow$14.94M$3.51M
Depreciation & amortization$2.35M$1.13M
Stock-based compensation$9.52M$13.50M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.